K. Tomiyoshi et al., Metabolic studies of [F-18-alpha-methyl]tyrosine in mice bearing colorectal carcinoma LS-180, ANTI-CANC D, 10(3), 1999, pp. 329-336
Brain and tumor uptake of [F-18-alpha-methyl]tyrosine (F-18-AMT) and the in
corporation into each of four fractions (lipid, RNA, DNA and protein) were
investigated in mice bearing LS180 colorectal carcinoma, Homogenized tissue
s were analyzed by the fractionation method into an acid-soluble fraction (
ASF) and an acid-precipitable fraction (APF). The APF was further investiga
ted to assess the incorporation of F-18-AMT into each fraction. Incorporati
on into four fractions of brain and tumor at 60 min post-injection was 20 a
nd 12%, respectively; 10% of the activity was incorporated to lipid in brai
n and 5% in tumor. There was 5, 2 and 2% incorporation with RNA, DNA and pr
otein, respectively. Metabolites in ASF were analyzed by high-performance l
iquid chromatography and thin-layer chromatography. There was only one radi
oactive peak, which corresponded to F-18-AMT. The incorporation of F-18-AMT
into lipid was twice that of F-18-AMT in tumor. The uptake of F-18-AMT in
tissues was rapid and accomplished before 30 min, and then slowly diffused
in blood. These results implied that F-18-AMT was metabolized to protein to
only a small extent and trapped as intact F-18-AMT in cells up to 60 min.
We conclude that F-18-AMT is a promising tracer for tumor imaging and quant
ification of the transport rate using two-compartment models. [(C) 1999 Lip
pincott Williams & Wilkins.].